# Eli Lilly and Company

Organization · id `cardio:eli-lilly` · Cardiovascular Atlas · release `f6f6f1b6f50379ed` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Eli Lilly; Lilly; ELI LILLY AND CO

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A drug company based in the United States. It is the lead sponsor of the SURPASS-CVOT trial, a collaborator on four SGLT2 inhibitor trials led by another drug company, and the applicant and listed manufacturer for Mounjaro.

## Technical summary

ROR 01qat3289. ClinicalTrials.gov lists Eli Lilly and Company as lead sponsor of NCT04255433 (SURPASS-CVOT) and as a collaborator on NCT01131676 (EMPA-REG OUTCOME), NCT03594110 (EMPA-KIDNEY), NCT03057977 (EMPEROR-Reduced) and NCT03057951 (EMPEROR-Preserved). The openFDA record for NDA215866 lists the sponsor as ELI LILLY AND CO and the manufacturer name as Eli Lilly and Company.

## Connected pages

- Manufactures: Tirzepatide (Mounjaro) (`cardio:mounjaro`)
- Sponsors: EMPA-KIDNEY: empagliflozin in a broad range of chronic kidney disease (`cardio:empa-kidney`)
- Sponsors: EMPA-REG OUTCOME: empagliflozin and cardiovascular outcomes in type 2 diabetes (`cardio:empa-reg-outcome`)
- Sponsors: EMPEROR-Preserved (`cardio:emperor-preserved`)
- Sponsors: EMPEROR-Reduced (`cardio:emperor-reduced`)
- Sponsors: SURPASS-CVOT: tirzepatide against dulaglutide on major cardiovascular events (`cardio:surpass-cvot`)

## Provenance

Content hash: ec9876e0813be1189de84e5edb2ec3af29f88fc4a1afba2f83badefffc1c466d
Last substantive edit: 2026-10-15
Evidence last checked: Not recorded